Previous publications from the ANSWER Program have shown that treatment with GH was efficacious in increasing HSDS from baseline in children with IGHD, MPHD, ISS, Noonan syndrome and Turner syndrome (7, 13). This evidence concerns the gene GH1 and Turner syndrome.